Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study

BACKGROUND: Intravenous recombinant tissue plasminogen activator (r-tPA) and urokinase (UK) are both recommended for the treatment of acute ischaemic stroke (AIS) in China, but with few comparative outcome data being available. We aimed to compare the outcomes of these two thrombolytic agents for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinhong, Li, Xiaoqiu, Xu, Yuming, Li, Runhui, Yang, Qingcheng, Zhao, Yong, Wang, Fengyun, Sheng, Baoying, Wang, Runqing, Chen, Shaoyuan, Wang, Lihua, Shen, Liying, Hou, Xiaowen, Cui, Yu, Wang, Duolao, Peng, Bin, Anderson, Craig S, Chen, Huisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717806/
https://www.ncbi.nlm.nih.gov/pubmed/33903179
http://dx.doi.org/10.1136/svn-2020-000640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717806/
https://www.ncbi.nlm.nih.gov/pubmed/33903179
http://dx.doi.org/10.1136/svn-2020-000640

Ejemplares similares